On 19 December 2016, the European Medicines Agency (“EMA”) published an updated version of the EMA guidance document concerning post-authorisation procedural advice for users of ...24 January 2017
Advisory Panel on Hospital Outpatient Payment Meeting Dates Set
- Monday, August 27, 2012, 1 p.m. to 5 p.m. EDT
- Tuesday, August 28, 2012, 9 a.m. to 5 p.m. EDT
- Wednesday, August 29, 2012, 9 a.m. to 5 p.m. EDT
The purpose of the Panel is to advise CMS on the clinical integrity of the Ambulatory Payment Classification (APC) groups and their associated weights, and hospital outpatient therapeutic supervision issues. Each year, the second meeting of the Panel is held after CMS has released the hospital outpatient prospective payment system proposed rule for the coming year, with the 2013 proposed rule expected in July of 2012. This meeting offers the opportunity for raising hospital outpatient payment issues to a group that can recommend actions for CMS to take, with such recommendations typically considered by CMS in the hospital outpatient final rule.
Regulation (EU) No 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (“the Clinical Trials Regulation”) was...24 January 2017
The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published a draft strategy for developing pharmacopoeial public quality standards for biological...20 January 2017